Results 41 to 50 of about 7,425 (214)

Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration [PDF]

open access: yes, 2023
Background: Kidney renal clear cell carcinoma (KIRC) is not sensitive to radiotherapy and chemotherapy, and only some KIRC patients can benefit from immunotherapy and targeted therapy.
Haixin Chen   +3 more
core   +1 more source

Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning [PDF]

open access: yes, 2023
BackgroundTo explicate the pathogenic mechanisms of cuproptosis, a newly observed copper induced cell death pattern, in Coronavirus disease 2019 (COVID-19).MethodsCuproptosis-related subtypes were distinguished in COVID-19 patients and associations ...
Dingyu Zhang   +5 more
core   +1 more source

Systematic analysis of the aberrances and functional implications of cuproptosis in cancer

open access: yesiScience, 2023
Summary: Cuproptosis is a novel form of cell death driven by a copper-dependent proteotoxic stress response whose comprehensive landscape in tumors remains unclear. Here, we comprehensively characterized cuproptosis-related genes (CRGs) across 33 cancers
Jiangbing Li   +3 more
doaj   +1 more source

Significance of cuproptosis- related genes in the diagnosis and classification of psoriasis

open access: yesFrontiers in Molecular Biosciences, 2023
Cuproptosis is a novel form of cell death linked to mitochondrial metabolism and is mediated by protein lipoylation. The mechanism of cuproptosis in many diseases, such as psoriasis, remains unclear.
Qingyuan Lin   +6 more
doaj   +1 more source

A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder

open access: yesFrontiers in Immunology, 2023
BackgroundUrothelial carcinoma of the bladder (UCB) is the most prevalent malignant tumor of the urinary system worldwide, which has a significant recurrence rate despite multiple treatment options available.
Huan Feng   +16 more
doaj   +1 more source

Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer

open access: yesNature Communications, 2023
Cuproptosis, caused by excessively high copper concentrations, is urgently exploited as a potential cancer therapeutic. However, the mechanisms underlying the initiation, propagation, and ultimate execution of cuproptosis in tumors remain unknown.
Lianhui Sun   +12 more
doaj   +1 more source

Immune Infiltration in Atherosclerosis is Mediated by Cuproptosis-Associated Ferroptosis Genes [PDF]

open access: yes, 2023
Aims: In this study, we aimed to identify cuproptosis-associated ferroptosis genes in the atherosclerosis microarray of the Gene Expression Omnibus (GEO) database and to explore hub gene-mediated immune infiltration in atherosclerosis.Background: Immune ...
Ang Gao   +8 more
core   +1 more source

Modulation of Bacterial Iron Homeostasis to Enhance Cuproptosis-like Death for the Treatment of Infected Diabetic Wound [PDF]

open access: yes
Cuproptosis, an emerging cell death pathway, offers an alternative approach for antimicrobial therapy, but it suffers from deficiencies and health risks.
Chang, Yuchen   +9 more
core   +1 more source

Head and Neck Squamous Cell Carcinoma: Cuproptosis-related Long Non-coding RNAs Predict Prognosis and Immunotherapeutic Response [PDF]

open access: yes
Objective Head and neck squamous cell carcinoma (HNSCC) has a poor prognosis because of high recurrence and metastasis rates and failure of immunotherapy caused by escape of immune cells.
Ding, Yao   +5 more
core   +2 more sources

Tumor glucose reprogramming suppresses cuproptosis: A review [PDF]

open access: yes
Cuproptosis is a copper-dependent form of regulated cell death that begins when ferredoxin 1 (FDX1) reduces Cu²⁺ to Cu¹⁺, allowing the ion to bind lipoylated enzymes of the tricarboxylic-acid (TCA) cycle, drive protein aggregation, dismantle iron–sulphur
Chen, Jing-Song   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy